We propose that an increased PSD95-LRP1 interaction might impair the interaction of the NR2B subunit with LRP1 since we observe the inverse binding capacity of the NR2B subunit to LRP1 after CIP treatment compared to PSD95 (compare upper panels in Figure 5D to 5F). This evidence concerns the gene LRP1 and hereditary sensory and autonomic neuropathy.